Celltrion : ConsolidatedFS_1H FY2023

Celltrion, Inc. and Subsidiaries

Condensed Consolidated Interim Financial Statements

June 30, 2023 and 2022

Celltrion, Inc. and Subsidiaries

Index

June 30, 2023 and 2022

Page (s)

Report on Review of Condensed Consolidated Interim Financial Statements	.................... 1 - 2
Condensed Consolidated Interim Financial Statements
Consolidated Interim Statements of Financial Position	3
Consolidated Interim Statements of Profit or Loss	4
Consolidated Interim Statements of Comprehensive Income	5
Consolidated Interim Statements of Changes in Equity	6
Consolidated Interim Statements of Cash Flows	7
Notes to the Consolidated Interim Financial Statements	8 - 50

Report on Review of Condensed Consolidated Interim Financial Statements

(English Translation of a Report Originally Issued in Korean)

To the Shareholders and Board of Directors of

Celltrion, Inc.

Reviewed Financial Statements

We have reviewed the accompanying condensed consolidated interim financial statements of Celltrion, Inc. and its subsidiaries (collectively referred to as the "Group"). These condensed consolidated interim financial statements consist of the consolidated interim statement of financial position of the Group as at June 30, 2023, and the related consolidated interim statements of profit or loss and comprehensive income for the three-month and six-month periods ended June 30, 2023, the related consolidated interim statements of changes in equity and cash flows for the six-month period ended June 30, 2023, and material accounting policy information and other selected explanatory notes, expressed in Korean won.

Management's Responsibility for the Financial Statements

Management is responsible for the preparation and presentation of these condensed consolidated interim financial statements in accordance with International Financial Reporting Standards as adopted by the Republic of Korea (Korean IFRS) 1034 Interim Financial Reporting, and for such internal control as management determines is necessary to enable the preparation of condensed consolidated interim financial statements that are free from material misstatement, whether due to fraud or error.

Auditor's Responsibility

Our responsibility is to express a conclusion on these condensed consolidated interim financial statements based on our review.

We conducted our review in accordance with quarterly or semi-annual review standards established by the Securities and Futures Commission of the Republic of Korea. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Korean Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe the accompanying condensed consolidated interim financial statements are not prepared, in all material respects, in accordance with Korean IFRS 1034 Interim Financial Reporting.

Other Matters

The consolidated interim statements of profit or loss, comprehensive income for the three-month and six- month periods ended June 30, 2022, and the consolidated interim statements of changes in equity and cash flows for the six-month period ended June 30, 2022, presented herein for comparative purposes, were reviewed by another auditor whose report dated August 16, 2022. Based on their review, nothing has come to their attention that causes them to believe the accompanying condensed consolidated interim financial statements do not present fairly, in all material respects, in accordance with Korean IFRS 1034 Interim Financial Reporting.

The consolidated statement of financial position as at December 31, 2022, and the consolidated statements of profit or loss, comprehensive income, changes in equity and cash flows for the year then ended, not presented herein, were audited by another auditor who expressed an unqualified opinion on those statements on March 20, 2023. The consolidated statement of financial position as at December 31, 2022, presented herein for comparative purposes, is consistent, in all material respects, with the above audited statement of financial position as at December 31, 2022.

Review standards and their application in practice vary among countries. The procedures and practices used in the Republic of Korea to review such financial statements may differ from those generally accepted and applied in other countries.

August 14, 2023

Seoul, Korea

This report is effective as of August 14, 2023, the review report date. Certain subsequent events or circumstances, which may occur between the review report date and the time of reading this report, could have a material impact on the accompanying condensed consolidated interim financial statements and notes thereto. Accordingly, the readers of the review report should understand that there is a possibility that the above review report may have to be revised to reflect the impact of such subsequent events or circumstances, if any.

2

Celltrion, Inc. and Subsidiaries

Consolidated Interim Statements of Financial Position June 30, 2023 and December 31, 2022

(in millions of Korean won)
	Notes
Assets
Current assets
Cash and cash equivalents	4
Short-term financial assets	4,5
Trade receivables, net	4,6,21,22
Other receivables, net	4,22
Inventories, net
Other current assets	14
Non-current assets
Long-term financial assets	4,5
Long-term trade receivables, net	4,6
Long-term other receivables	4
Investments in associates and joint ventures	7
Property, plant and equipment, net	8
Intangible assets, net	9
Other non-current assets
Deferred tax assets
Total assets
Liabilities
Current liabilities
Short-term financial liabilities	4,8,10,21
Trade payables	4,22
Other payables	4,11,22
Current tax liabilities
Provisions
Other current liabilities	14,22
Non-current liabilities
Long-term financial liabilities	4,8,10,21
Long-term other payables	4
Other non-current liabilities	22
Deferred tax liabilities
Total liabilities
Equity
Equity attributable to owners of the parent
Issued capital	12
Share premium	12
Retained earnings
Accumulated other comprehensive income
Other components of equity	12
Non-controlling interests	23
Total equity
Total liabilities and equity

	June 30, 2023
	(Unaudited)		December 31, 2022
	626,866		551,187
	48,306		43,277
	1,909,536		1,621,890
	57,316		32,200
	505,278		616,352
	58,611		64,886
	3,205,913		2,929,792
	28,517		29,274
	65,643		62,888
	92,684		91,154
	92,962		88,535
	1,059,397		1,007,038
	1,634,869		1,622,326
	25,793		28,461
	82,107		32,184
	3,081,972		2,961,860
	6,287,885		5,891,652
	667,850		665,012
	42,751		50,271
	314,497		320,244
	130,533		88,705
	1,600		1,487
	432,854		168,379
	1,590,085		1,294,098
	173,145		154,468
	7,910		7,576
	123,421		160,201
	543		1,105
	305,019		323,350
	1,895,104		1,617,448
	146,391		140,805
	861,533		853,172
	3,740,693		3,485,110
	59,686		48,745
	(552,276)		(388,472)
	136,754		134,844
	4,392,781		4,274,204
	6,287,885		5,891,652

The above condensed consolidated interim financial statements should be read in conjunction with the accompanying notes.

3